Morgan Stanley Maintains Overweight on Lemonade, Lowers Price Target to $75

Benzinga Newsdesk www.benzinga.com Negative 59.1%

Neg 59.1% Neu 0% Pos 0%

Morgan Stanley analyst Bob Huang maintains Lemonade (NYSE:LMND) with a Overweight and lowers the price target from $80 to $75.